SuperworthTriSalus Life Sciences market cap TLSI
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $221.1M
- Highest close in our data
- $370.7M
- Dec 2025
TriSalus Life Sciences is worth $221.1M at the close on Oct 23, 2026, at $3.59 a share.
That is down 13% over the last year and down 29% over five years.
Its highest close in our data was $370.7M in Dec 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $221.1M | $164.6M | $345.4M | −36% |
| 2025 | $343.3M | $149.5M | $370.7M | +133% |
| 2024 | $147.6M | $117.5M | $267.5M | −34% |
| 2023 | $222.4M | $29.5M | $318.8M | −29% |
| 2022 | $313.4M | $293.1M | $314.7M | +2% |
| 2021 | $308.8M | $302.5M | $311.9M | n/a |
Against its peers
Companies in Medical - Instruments & Supplies nearest TriSalus Life Sciences' size, closest first, today.
| Company | Market cap |
|---|---|
| TLSITriSalus Life Sciences | $221.1M |
| UTMDUtah Medical Products | $236.3M |
| PDEXPro DEX | $199.3M |
| INFUInfuSystem | $277.6M |
| EMBCEmbecta | $380.2M |
| KEQUKewaunee Scientific | $94.9M |
| TCMDTactile Systems Technology | $535.5M |
| MDXGMimedx | $569.9M |
| MOVMovado | $701.9M |
| APTAlpha Pro Tech | $56.7M |
| IRMDIradimed | $1.1B |
| Peer median | $328.9M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on TriSalus Life Sciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.